Roger K Strair, MD, PhD

Professor, Medicine, RWJMS The Cancer Institute of New Jersey (CINJ) 195 Little Albany Street, Room 3005 New Brunswick, NJ 08903 strairrk@umdnj.edu

Clinical Specialty: Leukemia, lymphoma

Degree

• MD, PhD from Harvard Medical School, Brigham and Women's Hospital
• MD, PhD from Harvard Medical School, Brigham and Women's Hospital
• MD, PhD from Harvard Medical School, Brigham and Women's Hospital
• MD, PhD from Albert Einstein College of Medicine
• BS from State University of New York

Grants

• Inhibition of NF-kB in AML Cells During Induction Chemotherapy (New Jersey Commission for Cancer Research)

Positions

• Professor of Medicine (09/2004 - Present)
  Internal Medicine
  Robert Wood Johnson Medical School/UMDNJ
• Director (01/1994 - Present)
  Hematologic Malignancies
  The Cancer Institute of New Jersey
• Medical Director (12/1995 - Present)
  Bone Marrow Transplant Unit
  Robert Wood Johnson University Hospital
• Associate Director, Bone Marrow Transplantation (09/2001 - Present)
  The Cancer Institute of New Jersey
  RWJMS/UMDNJ
• Associate Professor of Medicine (12/1993 - 09/2004)
  Internal Medicine
  Robert Wood Johnson Medical School/UMDNJ
• Assistant Professor of Medicine (09/1989 - 09/1993)
  Internal Medicine
  Yale University School of Medicine
• Instructor in Medicine, Harvard Medical School, Boston, MA (09/1987 - 09/1989)
  Internal Medicine
  Harvard Medical School

Honors

• Leadership in Patient Care Award
  The Cancer Institute of New Jersey (2001)
• Excellence in Teaching Award
  UMDNJ/RWJMS Internal Medicine Residency Program (2001)
• Excellence in Teaching Award
  UMDNJ/RWJMS Internal Medicine Residency Program (2000)
• Excellence in Teaching Award
  UMDNJ/RWJMS Internal Medicine Residency Program (1999)
• Distinguished Service in Patient Care Excellence Award
  Univ. of Medicine & Dentistry of NJ (1999)
• Dr. Edward Weinstein Award for Excellence in Medical Care
  Albert Einstein College of Medicine (1980)

Society

• American Society of Blood and Marrow Transplantation (2006 - Present)
• American Society of Clinical Oncology (1994 - Present)
• American Society of Hematology (1990 - Present)

Publications

• Saraiya B, Gounder M, Dutta J, Saleem A, Collazo C, Zimmerman L, Nazar A, Gharibo M, Schaar D, Lin Y, Shih W, Aisner J, Strair RK, Rubin EH. Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia Anticancer Drugs. 2008;
• Schaar D, Goodell L, Aisner J, Cui XX, Han JT, Chang R, Martin J, Grospe S, Dudeck L, Riley J, Lin Y, Rubin EH, Conney A, Strair RK. A Phase I Clinical Trial of 12-O-tetradecanoylphorbol-13-acetate for Patients with Relapsed/Refractory Malignancies. Cancer Chemotherapy Pharmacology. 2006;
• Ansell SM, Horwitz SM, Engert A, Khan KD, Lin T, Strair R, Keler T, Graziano R, Blanset D. Yellin M, Fischkoff S, Assad A, Borchmann P Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin’s lymphoma and anaplastic large-cell lymphoma Journal of Clinical Oncology. 2007;
• Medina DJ, Gharibo, M, Savage, P, Cohler A, Kuriyan M, Balsara B, Anand M, Schaar D, Krimmel T, Saggiomo K, Manago J, Talty L, Dudek L, Grospe S, Rubin A, Strair RK A Pilot Study of Allogeneic Cellular Therapy for Patients with Advanced Hematologic Malignancies Leukemia Research. 2008;
• Strair RK, Gharibo M, Schaar D, Rubin A, Harrison J, Aisner J, Lin H-S, Lin Y, Goodell L, Anand M, Balsara B, Dudek L, Rabson A, Medina DJ. Nuclear Factor-kappaB (NF-kB) modulation in patients undergoing induction chemotherapy for Acute Myelogenous Leukemia Clinical Cancer Research. 2008;
• Strair, R.K. An initiative to support non-industry-sponsored clinical research is needed. Clinical Cancer Research. 20075;

Research

• Blood and marrow transplantation
• Cellular therapy for patients with cancer
• Clinical trials for patients with hematologic malignancies
• Basic biology of hematologic malignancies
• Clinical care of patients with hematologic malignancies (leukemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma, myelodysplasia, aplastic anemis and other related diseases of the blood and/or bone marrow)